Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

被引：0
|
作者：
Ahrum Min
Seock-Ah Im
Debora Keunyoung Kim
Sang-Hyun Song
Hee-Jun Kim
Kyung-Hun Lee
Tae-Yong Kim
Sae-Won Han
Do-Youn Oh
Tae-You Kim
Mark J O’Connor
Yung-Jue Bang
机构：
[1] Seoul National University College of Medicine,Cancer Research Institute
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Seoul National University Hospital,Biomedical Research Institute
[4] Seoul International School,Department of Internal Medicine
[5] Chung Ang University College of Medicine,undefined
[6] AstraZeneca UK Ltd,undefined
[7] Macclesfield,undefined
来源：
Breast Cancer Research | / 17卷
关键词：
Comet Assay; HDAC Inhibition; SAHA; Combination Index; PARP Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
    Min, Ahrum
    Im, Seock-Ah
    Kim, Debora Keunyoung
    Song, Sang-Hyun
    Kim, Hee-Jun
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Tae-You
    O'Connor, Mark J.
    Bang, Yung-Jue
    BREAST CANCER RESEARCH, 2015, 17
  • [2] Histone deacetylases inhibitor SAHA enhances anti-tumor effects of poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in breast cancer cells
    Min, A.
    Im, S-A
    Kim, S.
    Song, S-H
    Lee, K-H
    Han, S-W
    Oh, D-Y
    Kim, T-Y
    Bang, Y-J
    CANCER RESEARCH, 2013, 73
  • [3] The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    Marks, PA
    CELL CYCLE, 2004, 3 (05) : 534 - 535
  • [4] Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
    Miyasaka, Aki
    Oda, Katsutoshi
    Ikeda, Yuji
    Wada-Hiraike, Osamu
    Kashiyama, Tomoko
    Enomoto, Atsushi
    Hosoya, Noriko
    Koso, Takahiro
    Fukuda, Tomohiko
    Inaba, Kanako
    Sone, Kenbun
    Uehara, Yuriko
    Kurikawa, Reiko
    Nagasaka, Kazunori
    Matsumoto, Yoko
    Arimoto, Takahide
    Nakagawa, Shunsuke
    Kuramoto, Hiroyuki
    Miyagawa, Kiyoshi
    Yano, Tetsu
    Kawana, Kei
    Osuga, Yutaka
    Fujii, Tomoyuki
    BMC CANCER, 2014, 14
  • [5] Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
    Aki Miyasaka
    Katsutoshi Oda
    Yuji Ikeda
    Osamu Wada-Hiraike
    Tomoko Kashiyama
    Atsushi Enomoto
    Noriko Hosoya
    Takahiro Koso
    Tomohiko Fukuda
    Kanako Inaba
    Kenbun Sone
    Yuriko Uehara
    Reiko Kurikawa
    Kazunori Nagasaka
    Yoko Matsumoto
    Takahide Arimoto
    Shunsuke Nakagawa
    Hiroyuki Kuramoto
    Kiyoshi Miyagawa
    Tetsu Yano
    Kei Kawana
    Yutaka Osuga
    Tomoyuki Fujii
    BMC Cancer, 14
  • [6] Anti-tumor and Anti-cancer Stem Cell Activity of a Poly ADP-ribose Polymerase Inhibitor Olaparib in Breast Cancer Cells
    Shimo, T.
    Kurebayashi, J.
    Kanomata, N.
    Yamashita, T.
    Moriya, T.
    Sonoo, H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S93 - S93
  • [7] Poly (ADP-ribose) polymerase-1 (PARP) expression in triple-negative breast cancer
    Possanzini, P.
    Biasi, M. O.
    Fumagalli, C.
    Barberis, M.
    Barile, M.
    Bonanni, B.
    Viale, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly (ADP-ribose) polymerase inhibitor olaparib
    Sarfo-Kantanka, Kofi
    Wilson, Andrew J.
    Steck, Alexandra
    Saskowski, Jeanette
    Khabele, Dineo
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [9] The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP-ribose polymerase inhibitor olaparib
    Sarfo-Kantanka, Kofi
    Wilson, Andrew J.
    Steck, Alexandra
    Saskowski, Jeanette
    Khabele, Dineo
    CANCER RESEARCH, 2016, 76
  • [10] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells.
    Munster, PN
    Rosen, N
    Rifkind, R
    Marks, P
    Richon, V
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3725S - 3725S
12345